Delivery Order SPE2DB22D3501-SPE2DB25FXF87
Award Date 9/9/25
Potential Completion Date 9/30/25
Potential Value $57K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Department of Defense, through its Medical Supply Chain division, awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of GAMUNEX-C 20 gram/200 milliliter vials valued at $56,646.72. This is a firm fixed-price, non-set-aside contract with a completion date of August 25, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. GAMUNEX-C is an immune globulin intravenous (human) treatment used for immunodeficiency and...
- The Defense Logistics Agency awarded a $11,636.00 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of GAMUNEX-C 40 gram/400 mL vials. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 14, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. GAMUNEX-C is an intravenous immunoglobulin (IVIG) therapy used to treat various immunodeficiency and autoimmune conditions, making it a critical...
- The U.S. Department of Defense Medical Supply Chain awarded a firm fixed-price delivery order valued at $13,963.20 to AmerisourceBergen Drug Corp for GAMUNEX-C 40 gram (1 unit) on September 3, 2025, with completion scheduled for September 24, 2025. This non-set-aside award was made competitively and represents a single delivery order under the company's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, valued at $999.99 million through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of GAMUNEX-C 10 gram/100 milliliter vials, with a ceiling value of $9,157.05 and an ultimate completion date of August 22, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania. GAMUNEX-C is an intravenous immunoglobulin used to treat immunodeficiency and autoimmune...
- The Defense Logistics Agency awarded a $41,178.10 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of GAMUNEX-C 40 gram/400 mL vials. This competitively awarded, firm fixed-price contract is non-set-aside and scheduled for completion by August 21, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. GAMUNEX-C is an immune globulin intravenous (human) product used in treating immune deficiency disorders and is a critical pharmaceutical...
- The Defense Logistics Agency awarded a $13,963.20 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of GAMUNEX-C 40 gram/400 mL vials. This is a firm fixed price contract with an ultimate completion date of September 24, 2025, and represents a non-set-aside competitive award. The delivery will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $7,080.84 delivery order contract to AmerisourceBergen Drug Corp for GAMUNEX-C (Immune Globulin Intravenous [Human]), a specialized pharmaceutical product supplied in 20 gram/200 milliliter vials. This firm fixed-price, non-set-aside contract is scheduled for completion by August 15, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine replenishment order under...
- The Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of GAMUNEX-C 40 gram/400 mL vials valued at $46,544.00, with completion scheduled for September 24, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. GAMUNEX-C is an immune globulin intravenous therapy used for treating...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of GAMUNEX-C 5 gram/50 milliliter vials valued at $3,036.70. This non-competitive delivery order, which must be completed by August 15, 2025, represents a firm fixed-price transaction under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, valued at $7,920.46, for 10 grams of GAMUNEX-C in 100 milliliter vials on September 2, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting open competition. The contract is set to complete on September 23, 2025, and represents performance at the vendor's location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery...